Previous 10 | Next 10 |
FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today provided a corporate update. On April 14, 2022, the Food and Drug Administration granted Zosano a twelve-month extension to April 20, 202...
Gainers: Lixte Biotechnology Holdings (LIXT) +205%. PolarityTE (PTE) +96%. Biodesix (BDSX) +29%. MiNK Therapeutics (INKT) +27%. Enservco (ENSV) +25%. Actinium Pharmaceuticals (ATNM) +21%. Compass Therapeutics (CMPX) +21%. Sunshine Biopharma (SBFM) +22%. Singularity Future Technology (SGLY) +2...
Shares of Zosano Pharma (NASDAQ:ZSAN) have fallen 24.4% in morning trade on Tuesday, as the biopharmaceutical company's stock started trading on a split-adjusted basis from market open today. The company on Monday had said its board approved a 1-for-35 reverse stock split, wherein every 35 sh...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips CarMax (NYSE: KMX ) stock is slipping on Tuesday after the company released its earnings report for the fourth quarter of fiscal 2022. Source: Jonathan Weiss / Shutterstock.com The bad news for KMX stock start...
Gainers: Lixte Biotechnology LIXT +263%. BioCardia BCDA +29%. Biodesix BDSX +27%. Aeglea BioTherapeutics AGLE +16%. Actinium Pharmaceuticals ATNM +14%. Losers: Hoth Therapeutics HOTH -30%. Altamira Therapeutics CYTO -29%. Myovant Sciences (MYO...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In pre-market trading, the share price of Zosano Pharma (NASDAQ: ZSAN ) stock is incredibly soaring nearly 3,000%. But the total value of all of the outstanding shares of ZSAN stock has actually declined. Source: i...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday! Source: f11photo/Shutterstock.com We’ve got a reverse stock split, clinical trial...
Zosano Pharma (NASDAQ:ZSAN) has announced a 1-for-35 reverse stock split of its common shares on Monday. That means every 35 shares of the company’s common stock will be automatically reclassified into 1 new share of the common stock. The shares will begin trading on a split-adjusted b...
FREMONT, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its Board of Directors has approved a 1-for-35 reverse stock split of the company’s common stock. The reverse stock split...
How Penny Stocks Will Be Affected by the 431K Jobs Added in March Right now, penny stocks are a hot topic of conversation, and with the unemployment rate down, it’s no surprise that people are looking for the best penny stocks to buy. But before you start buying penny stocks ...
News, Short Squeeze, Breakout and More Instantly...
Zosano Pharma Corporation Company Name:
ZSAN Stock Symbol:
NASDAQ Market:
Zosano Pharma Corporation Website:
FREMONT, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on June 1, 2022 it filed a voluntary petition for relief under chapter 11 of title 11 (“Chapter 11”) of the United ...
FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022. All share and per share information included in these financial results a...